PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1771-1779

  Garaulet, Marta ^a,b   Smith, Caren E ^b   Hernández González, Teresa ^a   Lee, Yu Chi ^b   Ordovás, Jose M ^b,c  

^a UNIVERSITY OF MURCIA   (Spain)

^b TUFTS UNIVERSITY   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Fat intake; Gene environment interaction; Obesity; Peroxisome proliferator activated receptor ; Polymorphism

Indexed keywords

INSULIN; MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BLOOD; BODY MASS; DIET THERAPY; DRUG EFFECT; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; GENE LOCUS; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTERVIEW; MALE; MEDITERRANEAN DIET; METABOLISM; MIDDLE AGED; OBESITY; PHENOTYPE; SPAIN; STATISTICAL MODEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; AGED; ALLELES; ANTHROPOMETRY; BODY MASS INDEX; DIET, MEDITERRANEAN; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FEMALE; FOOD HABITS; GENETIC LOCI; GENOTYPE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC; PPAR GAMMA; SPAIN; WEIGHT LOSS; YOUNG ADULT;

EID: 82955187076     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100437     Document Type: Article

References (54)

1. Desvergne, B., Wahli, W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20, 649-688.
2. Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., et al., A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity. Lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20, 284-287.
3. Huguenin, G. V., Rosa, G., The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br. J. Nutr. 2010, 104, 488-497.
4. Chistiakov, D. A., Potapov, V. A., Khodirev, D. S., Shamkhalova, M. S. et al., The PPARgamma Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects. Diab. Vasc. Dis. Res. 2010, 7, 56-62.
5. Vimaleswaran, K. S., Radha, V., Ghosh, S., Majumder, P. P. et al., A haplotype at the UCP1 gene locus contributes to genetic risk for type 2 diabetes in Asian Indians (CURES-72). Metab. Syndr. Relat. Disord. 2010, 8, 63-68.
6. Wang, F., Han, X. Y., Ren, Q., Zhang, X. Y. et al., Effect of genetic variants in KCNJ11. ABCC8. PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin. Med. J. (Engl.) 2009, 122, 2477-2482.
7. Rosen, E. D., Hsu, C. H., Wang, X., Sakai, S. et al., Spiegelman BM. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002, 16, 22-26.
8. Stefanski, A., Majkowska, L., Ciechanowicz, A., Frankow, M. et al., Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes. insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Arch. Med. Res. 2006, 37, 736-43.
9. Tellechea, M. L., Aranguren, F., Pérez, M. S., Cerrone, G. E. et al., Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status. Circ. J. 2009, 73, 2118-2124.
10. Tontonoz, P., Hu, E., Spiegelman, B. M., Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995, 5, 571-576.
11. Martinez, J. A., Parra, M. D., Santos, J. L., Moreno-Aliaga, M. J. et al., Genotype-dependent response to energy-restricted diets in obese subjects: towards personalized nutrition. Asia Pac. J. Clin. Nutr. 2008, 17, 119-122.
12. Matsuo, T., Nakata, Y., Katayama, Y., Iemitsu, M. et al., PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring) 2009, 17, 1924-1931.
13. Adamo, K. B., Dent, R., Langefeld, C. D., Cox, M. et al., Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 2007, 15, 1068-1075.
14. Sesti, G., Perego, L., Cardellini, M., Andreozzi, F. et al., Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J. Clin. Endocrinol. Metab. 2005, 90, 5064-5069.
15. Garaulet, M., Pérez-Llamas, F., Zamora, S., Tébar, F. J., Weight loss and possible reasons for dropping out of a dietary/behavioural programme in the treatment of overweight patients. J. Hum. Nutr. Diet 1999, 12, 219-227.
16. Corbalán, M. D., Morales, E. M., Canteras, M., Espallardo, A. et al., Effectiveness of cognitive-behavioral therapy based on the Mediterranean diet for the treatment of obesity. Nutrition 2009, 25, 861-869.
17. Serra-Majem, L., Aranceta, J., SENC Working Group on Nutritional Objectives for the Spanish Population. Spanish Society of Community Nutrition. Nutritional objectives for the Spanish population. Consensus from the Spanish Society of Community Nutrition. Public Health Nutr. 2001, 4, 1409-1413.
18. Pérez-Llamas, F., Garaulet, M., Herrero, F., Palma, J. T. et al., Multivalent informatics application for studies of the nutritional status of the population. Assessment of food intake. Nutr. Hosp. 2004, 19, 160-166.
19. Mataix, J., Mañas, M., Llopis, J., Martínez, E., (Table of composition of Spanish foods) Tabla de composición de alimentos españoles. Granada. Spain: Instituto de Nutrición y Tecnología. Universidad de Granada, 1995 (Spanish).
20. Moreiras, O., Carvajal, A., Cabrera, L., (Tables of composition of foods) Tablas de composición de alimentos, Ediciones Pirámide, SA, Madrid 1995 (Spanish).
21. HelixTree Manual. Version 5.3.0. (updated 2010 July 1). (x133-75400023.7).
22. Ferrario, V. F., Sforza, C., Schmitz, J. H., Miani, A., Jr., Taroni, G., Fourier analysis of human soft tissue facial shape: Sex differences in normal adults. J. Anat. 1995, 187, 593-602.
23. Havel, R. J., Eder, H. A., Bragdon, J. H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345-1353.
24. Warnick, G. R., Benderson, J., Albers, J. J., Dextran sulfate-Mg21 precipitation procedure for quantitation of high-densitylipoprotein cholesterol. Clin. Chem. 1982, 28, 1379-1388.
25. Friedewald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
26. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A. et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.
27. Thamer, C., Haap, M., Volk, A., Maerker, E. et al., Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2. Horm. Metab. Res. 2002, 34, 132-136.
28. Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P. et al., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316, 1331-1336.
29. Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M. et al., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316, 1336-1341.
30. Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J. et al., A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316, 1341-1345.
31. Yen, C. J., Beamer, B. A., Negri, C., Silver, K. et al., Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem. Biophys. Res. Commun. 1997, 241, 270-274.
32. Ereqat, S., Nasereddin, A., Azmi, K., Abdeen, Z., Amin, R., Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the palestinian type 2 diabetic patients. PPAR Res. 2009, 874126. DOI: 10.1155/2009/874126.
33. Huguenin, G. V., Rosa, G., The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br. J. Nutr. 2010, 104, 488-497.
34. Gouda, H. N., Sagoo, G. S., Harding, A. H., Yates, J. et al., The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 2010, 171, 645-655 (Review).
35. Stefanski, A., Majkowska, L., Ciechanowicz, A., Frankow, M. et al., Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Arch. Med. Res. 2006, 37, 736-743.
36. Kozarova, M., Javorsky, M., Stancakova, A., Dobrikova, M. et al., Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population. Bratisl Lek Listy 2010, 111, 150-152.
37. Milewicz, A., Tworowska-Bardziñska, U., Dunajska, K., Jêdrzejuk, D., Lwow, F., Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women. Exp. Clin. Endocrinol. Diabetes 2009, 117, 628--632.
38. Li, S., Chen, W., Srinivasan, S. R., Boerwinkle, E., Berenson, G. S., Bogalusa Heart Study. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study. Diabetes 2003, 52, 1265-1269.
39. Ruchat, S. M., Weisnagel, S. J., Vohl, M. C., Rankinen, T. et al., Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects. Exp. Clin. Endocrinol. Diabetes 2009, 117, 455-459.
40. Memisoglu, A., Hu, F. B., Hankinson, S. E., Manson, J. E. et al., Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet. 2003, 12, 2923-2929.
41. Soriguer, F., Morcillo, S., Cardona, F., Rojo-Martínez, G. et al., Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J. Nutr. 2006, 136, 2325-2330.
42. Oh, E. Y., Min, K. M., Chung, J. H., Min, Y. K. et al., Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. J. Clin. Endocrinol. Metab. 2000, 85, 1801-1804.
43. Ringel, J., Engeli, S., Distler, A., Sharma, A. M., Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Biochem. Biophys. Res. Commun. 1999, 254, 450-453.
44. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H. et al., PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 1999, 4, 597-609.
45. Yamauchi, T., Waki, H., Kamon, J., Murakami, K. et al., Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 2001, 108, 1001-1013.
46. Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J. et al., A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity. Lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20, 284-287.
47. Luan, J., Browne, P. O., Harding, A. H., Halsall, D. J. et al., Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001, 50, 686-689.
48. Vidal-Puig, A., Jimenez-Liñan, M., Lowell, B. B., Hamann, A. et al., Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 1996, 97, 2553-2561.
49. Nicklas, B. J., van Rossum, E. F., Berman, D. M., Ryan, A. S. et al., Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001, 50, 2172-2176.
50. Franks, P. W., Jablonski, K. A., Delahanty, L., Hanson, R. L. et al., Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007, 50, 2451-2460.
51. Tontonoz, P., Spiegelman, B. M., Fat and beyond: The diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77, 289-312.
52. Nolan, C. J., Larter, C. Z., Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it? J. Gastroenterol. Hepatol. 2009, 24, 703-706.
53. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H. et al., PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 1999, 4, 597-609.
54. Llaverias, G., Vázquez-Carrera, M., Sánchez, R. M., Noé, V. et al., Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J. Lipid Res. 2004, 45, 2015-2024.